In contrast, our retrospective case study which used conversion to Alzheimer’s disease or dementia as an outcome measure suggests the potential neuroprotective benefit of interrupting TNF signaling between the periphery and the brain. The gene discussed is TNF; the disease is Alzheimer disease.